Survival after liver resection for cancer

Foster, James H.

doi:10.1002/1097-0142(197009)26:3<493::aid-cncr2820260302>3.0.co;2-7

Cited by 134 publications

(37 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Foster's collection 296 patients with primary liver cancer from the pre-1970 literature, the 2-and 5-year determinant survival rates were 33.3% and 14% overall, but they were 59% and 36% for nonAsian, and 23% and 6% in Asian patients. 7 The results of liver resection for metastatic liver tumors also have been encouraging, particularly since such resections can be performed with minimum mortality. Foster reviewed more than 400 hospital records of patients with metastatic liver tumor from colorectal cancer and reported in 1978 two-and five-year determinant survival, respectively, of 44% and 22%, excluding the patients who died during the initial hospitalization.…”

Section: Discussionmentioning

confidence: 99%

Experience with 150 Liver Resections

1983

View full text Add to dashboard Cite

One hundred fifty liver resections were performed with an operative mortality rate of 4%. Indications for liver resections were 43 primary liver malignancies, 43 metastatic liver tumors, and 64 benign liver diseases. The 3-year actuarial survival rate after treatment of primary liver malignancy was 56%, and that after treatment of metastatic liver tumors was 66%. All but one of 59 patients with benign disease who survived operation were alive without development of late symptoms or complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Experience with 150 Liver Resections

1983

View full text Add to dashboard Cite

show abstract

“…*.eJ4 Partial he atectomy is feasible the operative mortality and morbidity are high, and recurrence in the remaining lobe is the rule rather than the exception. 4 Most patients present with inoperable tumor, and since the liver is intolerant even to low-dose radiation,* chemotherapy seems to be the only reasonable approach for palliation. Various forms of systemic chemotherapy have been used by many workers, without significant effect.…”

mentioning

confidence: 99%

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

Olweny

Toya

Katongole‐Mbidde

et al. 1975

Cancer

176

View full text Add to dashboard Cite

In a Phase I1 clinical trial, 14 patients with histologically proven primary hepatocellular carcinoma were treated with adriamycin administered intravenously a t a dose of 75 mg/mz every 3 weeks. All 11 evaluable p a t i w t s responded with 3 exhibiting complete tumor regression after two, three, and five courses of adriamycin respectively. The remissipn durations for these 3 were 3, 6, and 7 months, a n d their survivals were 8, 9, and I3 months, respectively. The median survival of the evaluable patients is 8 months (range 1-13 months). The side effects encountered included myelosuppression, anorexia, nausea, vomiting, and alopecia. Adriamycin seems to be an effective agent in hepatocellular carcinoma. Further trials a r e underway t o test its true efficacy both singly and in combination with other drugs i n the management of this tumor.

show abstract

“…In southeast Asia, HCCs frequently appear in association with cirrhosis of the liver and results of hepatectomy are poor. Foster [13] reported a 5-year survival rate after hepatic resection of 36% for non-Asians and 6% for Asians. Systematic segmentectomy or subsegmentectomy can avoid unnecessary wide hepatic resection that may lead to hepatic failure in cases of HCCs associated with liver cirrhosis.…”

Section: Discussionmentioning

confidence: 99%

Intraoperative sonography of hepatocellular carcinoma: Detection of lesions and validity in surgical resection

Choi

Han

Song

et al. 1991

Gastrointest Radiol

View full text Add to dashboard Cite

Eighty-six hepatocellular carcinomas (HCCs) in 67 patients were examined by intraoperative sonography. Sensitivity for detecting tumors with intraoperative sonography was compared with sonography, computed tomography (CT), hepatic angiography, and CT after intraarterial injection of iodized poppy-seed oil (Lipiodol-CT). The overall sensitivities were 76% with sonography, 86% with CT, 89% with angiography, 96% with Lipiodol-CT, and 98% with intraoperative sonography. The differences in sensitivity between intraoperative sonography and sonography (p less than 0.01), CT (p less than 0.01), and angiography (p less than 0.05) were significant. In 35 lesions smaller than 2 cm, the sensitivities of Lipiodol-CT and intraoperative sonography were high (91 and 94%, respectively). In operating field, tumors were invisible in 36 (42%) and nonpalpable in 31 of 86 cases (36%). In 35 tumors smaller than 2 cm, invisible tumors were 66% and nonpalpable tumors were 63%. However, 84 of 86 cases (98%) could be localized with intraoperative sonography. These results suggest that intraoperative sonography is the final diagnostic imaging procedure before surgical resection of tumors and in cases of invisible and nonpalpable tumors in the operating field, this procedure is mandatory to improve surgical results.

show abstract

Survival after liver resection for cancer

Cited by 134 publications

References 62 publications

Experience with 150 Liver Resections

Experience with 150 Liver Resections

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

Intraoperative sonography of hepatocellular carcinoma: Detection of lesions and validity in surgical resection

Contact Info

Product

Resources

About